Cetera Investment Advisers Laboratory Corp Of America Holdings Transaction History

Cetera Investment Advisers

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 24, 2024	BUY	$209.01 - $232.56 $2.61 Million - $2.9 Million	12,480 Added 523.71%	14,863 $3.25 Million
Q1 2024 May 14, 2024	SELL	$209.01 - $232.56 $803,016 - $893,495	-3,842 Reduced 61.72%	2,383 $520,000
Q4 2023 Feb 13, 2024	SELL	$197.69 - $227.29 $64,446 - $74,096	-326 Reduced 4.98%	6,225 $1.41 Million
Q3 2023 Nov 14, 2023	BUY	$201.05 - $221.7 $186,373 - $205,515	927 Added 16.48%	6,551 $1.32 Million
Q2 2023 Aug 09, 2023	SELL	$211.93 - $241.33 $101,726 - $115,838	-480 Reduced 7.86%	5,624 $1.36 Million
Q1 2023 May 15, 2023	SELL	$213.32 - $257.83 $35,837 - $43,315	-168 Reduced 2.68%	6,104 $1.4 Million
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $608,715 - $743,922	2,988 Added 90.99%	6,272 $1.48 Million
Q3 2022 Nov 10, 2022	SELL	$204.81 - $262.19 $245,157 - $313,841	-1,197 Reduced 26.71%	3,284 $673,000
Q2 2022 Aug 11, 2022	SELL	$213.86 - $277.87 $139,009 - $180,615	-650 Reduced 12.67%	4,481 $1.05 Million
Q1 2022 May 13, 2022	SELL	$259.82 - $298.18 $38,453 - $44,130	-148 Reduced 2.8%	5,131 $1.35 Million
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $22,814 - $26,393	-84 Reduced 1.57%	5,279 $1.66 Million
Q3 2021 Nov 16, 2021	BUY	$274.82 - $308.34 $77,774 - $87,260	283 Added 5.57%	5,363 $1.51 Million
Q2 2021 Aug 13, 2021	BUY	$251.87 - $278.14 $212,578 - $234,750	844 Added 19.92%	5,080 $1.4 Million
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $76,625 - $95,381	-374 Reduced 8.11%	4,236 $1.08 Million
Q4 2020 Feb 17, 2021	BUY	$186.91 - $214.42 $861,655 - $988,476	4,610 New	4,610 $938,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.